References
- Aoki F, Sando Y, Tajima S et al. 2001. Invasive pulmonary aspergillosis in a puerperant with drug-induced agranulocytosis. Internal Medicine 40:1128–1131.
- Fujiwaki R, Hata T, Hata K et al. 1995. Effective treatment of drug-induced agranulocytosis using recombinant human granulocyte colony stimulating factor in pregnancy. Gynecologic and Obstetric Investigation 40:276–277.
- Ikushima Y, Kobayashi H, Imaishi K et al. 1990. Ritodrine-induced agranulocytosis. Archives of Gynecology and Obstetrics 248:53–54.
- Kikkawa M, Matsubara S, Takatoku M et al. 2008. Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia. Journal of Obstetrics and Gynaecology Research 34:286–290.
- Muro M, Shono H, Oga M et al. 1991. Ritodrine-induced agranulocytosis. International Journal of Gynaecology and Obstetrics 36:329–331.
- Naranjo CA, Busto U, Sellers EM et al. 1981. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 30:239–245.
- Tsukimori K, Morokuma S, Yoshimura T et al. 2008. Neutropenia induced in a patient by treatment with ritodrine: in vitro evaluation of myeloid progenitor colony-forming cells. British Journal of Clinical Pharmacology 65:149–150.
- Wang-Cheng R, Davidson BJ. 1986. Ritodrine-induced neutropenia. American Journal of Obstetrics and Gynecology 154:924–925.
- Yasuda R, Makino Y, Matsuda Y et al. 2012. Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms. Journal of Obstetrics and Gynaecology Research 38:574–577.